Another group studied the effect of the inhibition of the Lcn-2-targeted pathway using ER-negative (ER-) breast cancer and revealed that the transcription factor CCAAT enhancer-binding protein ζ (C/EBP ζ) plays a role in Lcn-2 expression. The gene discussed is CEBPZ; the disease is breast cancer.